Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 7 of 7 citing Whiteley: Should diabetes be considered a coronary heart disease risk equivalent?. (0.10 sec) 

Metabolic syndrome in the acute care setting


PM Selig - AACN Advanced Critical Care, 2006 - journals.lww.com
The metabolic syndrome is a clinical condition that is a powerful predictor for
cardiovascular morbidity and mortality. Hypertension, abdominal obesity, high
blood glucose levels, and abnormal blood lipid levels characterize ...
Cited by 7 - Related articles - BL Direct - All 4 versions

Coronary artery calcification, serum lipids, lipoproteins, and peripheral inflammatory …


P Gunczler, R Lanes, A Soros, L Verdu, Y … - The Journal of pediatrics, 2006 - Elsevier
Neither adolescents with type 1 diabetes nor healthy control subjects presented
with evidence of CAC. Fasting lipids, Apo A, Apo B, CRP, and MMP-9
concentrations were similar between diabetic subjects and control subjects. ...
Cited by 8 - Related articles - All 16 versions

Prevalence of multiple cardiac risk factors in US adults with diabetes

- librapharm.co.uk [PDF] 
M McCollum, SL Ellis, EH Morrato, PW … - Current Medical Research and Opinion®, 2006 - informahealthcare.com
Marianne McColluma, Samuel L. Ellisa, Elaine h. Morratoa,b and Patrick W.
Sullivana ... Address for correspondence: Marianne McCollum, PhD, 4200 East 9th
Avenue, University of Colorado at Denver and Health Sciences Center, School ...
Cited by 5 - Related articles - BL Direct - All 8 versions

All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining …


KB Doshi, SR Kashyap, DM Brennan, BM Hoar … - Diabetes, Obesity & Metabolism, 2009 - nursing2008.com
Aim: It is unclear if metabolic syndrome (MS) is equal to type 2 diabetes
mellitus (DM) in predicting cardiovascular disease (CVD) risk and mortality, and
its prognostic value compared to Framingham risk model is controversial. We ...
Related articles - Cached - All 5 versions

Effects of Acarbose on Proinsulin and Insulin Secretion and their Potential Significance …


C Rosak, G Mertes - Current Diabetes Reviews, 2009 - ingentaconnect.com
Abstract: The alpha-glucosidase inhibitor acarbose is administered to control
blood glucose levels in type 2 diabetic pa- tients and, in several countries, in
those with impaired glucose tolerance. The efficacy and safety of the drug ...
Related articles - All 2 versions

The increase of diabetes mortality burden among Brazilian adults


SM Barreto, VMA Passos, SKF Almeida, TD … - Revista Panamericana de Salud Pública, 2007 - SciELO Public Health
Rev Panam Salud Publica/Pan Am J Public Health 22(4), 2007 ... Sandhi Maria
Barreto, 1 Valeria Maria Azeredo Passos, 1 ... Suzanne Kelly Ferreira Almeida,
1 and Tiago Duarte Assis 1 ... Objective. To estimate diabetes-related ...
Related articles - View as HTML - BL Direct - All 12 versions

[PDF] América Latina y el Caribe1


M Monteverde, B Novak - alapop.org
Page 1. El efecto de la obesidad sobre la longevidad: Un análisis comparado para
América Latina y el Caribe Malena Monteverde Beatriz Novak Mesa 06. ...
Related articles - View as HTML - All 2 versions


 


Go to Google Home - About Google - About Google Scholar

©2009 Google